776 abstracts found.



Results filter

Supporting family carers: International evidence

Year:

Session type:

Sheila Payne1
1Lancaster University, Lancaster, UK

Supporting family carers: International evidence

Year:

Session type:

Gunn Grande1
1University of Manchester, Manchester, UK

Supporting family carers: Identifying differences between urban and rural care at the end of life in Canada 

Year:

Session type:

Kevin Brazil1
1Queen's University Belfast, Northern Ireland, UK

Supporting family carers: Outcome of caregiving in nationwide register-based Scandinavian studies

Year:

Session type:

Mai-Britt Guldin1
1Research Unit for General Practice, Aarhus, Denmark

Using next-generation sequencing to transform clinical practice

Year:

Session type:

Nazneen Rahman1
1The Institute of Cancer Research, London, UK

The Mainstreaming Cancer Genetics Programme: Integrating genetic testing into routine clinical practice

Year:

Session type:

Clare Turnbull1
1The Institute of Cancer Research, London, UK

The Heidelberg Center for Personalized Oncology

Year:

Session type:

Christof von Kalle1
1National Center of Tumor Diseases, Heidelberg and German Cancer Research Center (DKFZ), Germany

Introduction: Clinical application of translational research in breast cancer

Year:

Session type:

John Yarnold1
1The Institute of Cancer Research, London, UK

Using GEMM and PDX models of pancreatic cancer to identify new therapeutic opportunities in PDAC

Year:

Session type:

Owen Sansom1
1Cancer Research UK Beatson Institute, Glasgow, UK

Cervical cancer – problem solved?

Year:

Session type:

Peter Sasieni1
1Wolfson Institute of Preventive Medicine, Queen Mary University, London, London, UK

The biology and clinical exploitation of BRAF and RAS signalling in cancer

Year:

Session type:

Richard Marais1
1The Cancer Reserch UK Manchester Institute, Manchester, UK

Chromosomal instability and hopeful monsters: A driving force for cancer heterogeneity and evolution

Year:

Session type:

Charles Swanton1
1Cancer Research UK London Research Institute and University College London Cancer Institute, London, UK

Inflammation and cancer: Reprogramming the immune microenvironment as an anti-cancer therapeutic strategy

Year:

Session type:

Lisa M Coussens1
1Knight Cancer Institute, Oregon Health & Sciences University, Portland, USA

Cancer Research UK Lifetime Achievement Award winner: Polygenic susceptibility: What might it tell us?

Year:

Session type:

Bruce Ponder1
1Cancer Research UK Cambridge Institute, Cambridge, UK

Defective DNA strand break repair, genome instability and cancer

Year:

Session type:

Stephen C West1
1Cancer Research UK London Research Institute, South Mimms, UK

The application of translational science in non-small cell lung cancer (NSCLC): Successes, failures and pitfalls

Year:

Session type:

Frances A Shepherd1
1Princess Margaret Hospital and University of Toronto, Toronto, Canada

Improving value in cancer care: The case for palliative medicine

Year:

Session type:

R Sean Morrison1
1Hertzberg Palliative Care Institute, National Palliative Care Research Center, and Mount Sinai Medical Center, New York, USA

Cancer predisposition genes: Past glories, future imperatives

Year:

Session type:

Nazneen Rahman1
1The Institute of Cancer Research and The Royal Marsden Hospital Foundation Trust, London, UK

Mitochondrial dysfunction and autophagy in tumour progression and metastasis

Year:

Session type:

Kay Macleod1
1The University of Chicago, Chicago, USA

DNA damage: An inherent flaw of apoptosis-mediated tumour suppression?

Year:

Session type:

Stephen Tait1
1The Beatson Institute for Cancer Research and University of Glasgow, Glasgow, UK

Translational metabolic treatments for breast cancer

Year:

Session type:

Adrian L Harris1
1University of Oxford, Oxford, UK

Application of risk prediction to breast cancer prevention

Year:

Session type:

Douglas Easton1
1University of Cambridge, Cambridge, UK

Immunotherapy of childhood cancer

Year:

Session type:

John Anderson1
1Institute of Child Health, London, UK

CCLG prizewinner: RNA helicase A is essential for 1p36 gene KIF1Bb tumour suppression in neuroblastomas

Year:

Session type:

Zhi Xiong Chen1
1Ludwig Institute for Cancer Research, Solna, Sweden and National University of Singapore, Singapore, Singapore

T cell-based immunotherapy approaches for neuroblastoma

Year:

Session type:

Karin Straathof1
1University College London Institute of Child Health and Great Ormond Street Hospital, London, UK, London, UK

Haploidentical transplantation as a platform for post-transplant immune therapy in childhood leukaemia

Year:

Session type:

Rupert Handgretinger1
1Children’s University Hospital, Tübingen, Germany

Natural killer T (NKT) cells as a novel platform for cancer immunotherapy with chimeric antigen receptors

Year:

Session type:

Leonid S Metelitsa1
1Baylor College of Medicine, Houston, USA

Refractory breathlessness: Mechanisms and management

Year:

Session type:

Miriam Johnson1
1Hull York Medical School, York, UK

Refractory breathlessness: Mechanisms and management

Year:

Session type:

David Currow1
1Flinders University, Adelaide, Australia

From biology to therapy: a translational approach to breathlessness

Year:

Session type:

Richella Ryan1,2
1University of Cambridge, Cambridge, UK, 2Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

More than a clinical sign or symptom: The experience of breathlessness in advanced illness

Year:

Session type:

Marjolein Gysels1,2
1Cicely Saunders Institute, King's College London, London, UK, 2Centre for Social Science and Global Health, University of Amsterdam, Amsterdam, The Netherlands

The ‘end game’ for tobacco control in the UK: Key priorities for science and policy to reduce smoking

Year:

Session type:

Linda Bauld1
1University of Stirling, Stirling, UK

Challenges in realising the end game: Dealing with the tobacco industry

Year:

Session type:

Anna B Gilmore1
1University of Bath, Bath, UK

The international context for moving toward the ‘end game’ for tobacco control in the United Kingdom

Year:

Session type:

Geoffrey T Fong1,2
1University of Waterloo, Waterloo, Canada, 2Ontario Institute for Cancer Research, Toronto, Canada

Smoking prevention: What we need to do

Year:

Session type:

Amanda Amos1
1University of Edinburgh, Edinburgh, UK

The importance of knowing which way is up – the role of polarity in tumour suppression

Year:

Session type:

Buzz Baum1
1University College London, London, UK

Functional characterisation of new molecular mechanisms involved in epithelial lumen morphogenesis

Year:

Session type:

Fernando Martin-Belmonte1
1CSIC-UAM Centro de Biología Molecular Severo Ochoa

Fat cadherins in the regulation of planar polarity, tissue growth and mitochondrial activity

Year:

Session type:

Helen McNeill1
1University of Toronto and Lunenfeld-Tanenbaum Institute of Mount Sinai Hospital, Toronto, Canada

Cancer immunology and immunotherapy: Building on success

Year:

Session type:

Sergio Quezada1
1University College London Cancer Institute, London, UK

Linking cancer exomes to cancer immunotherapy

Year:

Session type:

Ton Schumacher1
1Netherlands Cancer Institute, Amsterdam, The Netherlands

Chimeric antigen receptor modified T cells: Does receptor design and cell product composition matter?

Year:

Session type:

Stanley Riddell1,2
1Fred Hutchinson Cancer Research Center, 2University of Washington, Seattle, USA

The FAP+ stromal cell establishes dominant immune suppression in an autochthonous model of pancreatic ductal adenocarcinoma

Year:

Session type:

Douglas Fearon1
1University of Cambridge, Cambridge, UK

Intravital microscopy of cancer invasion, plasticity and integrin function: Targeting cancer resistance

Year:

Session type:

Peter Friedl1,2
1Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 2The University of Texas, MD Anderson Cancer Center, Houston, USA

Cell migration in tumours

Year:

Session type:

Erik Sahai1,2
1Cancer Research UK, London, UK, 2London Research Institute, London, UK

Plasticity and physical mechanisms of cell migration in confinement

Year:

Session type:

Ewa Paluch1
1University College London, London, UK

Life-altering late effects and their management in survivors of childhood malignancy

Year:

Session type:

Rod Skinner1,2
1Great North Children’s Hospital, Newcastle, UK, 2Royal Victoria Infirmary, Newcastle, UK

Frequency, timing and causes of late mortality in survivors of childhood malignancy

Year:

Session type:

Raoul Reulen1
1University of Birmingham, Birmingham, UK

Late effects of childhood cancer: What are the consequences for long-term survivors and how can they be reduced?

Year:

Session type:

Melissa M Hudson1
1St Jude Children’s Research Hospital, Memphis, USA

Molecular stratification and clinical management of adult high-grade glioma

Year:

Session type:

Colin Watts1
1University of Cambridge, Cambridge, UK

Predictive markers for response to adjuvant procarbazine, lomustine (CCNU) and vincristine (PCV) in anaplastic oligodendrogliomas and oligoastrocytomas

Year:

Session type:

Pim French1
1Erasmus MC, Rotterdam, The Netherlands